Vericel manufactures advanced cell therapies for the sports medicine and severe burn care markets. The goal of our therapies is to repair or restore a patient’s damaged tissues or organs using their own cells. Please use the links to the right to visit our product websites.

NASDAQ: VCEL

$25.82 0.28 (1.1%)
Day High: $26.82
Day Low: $25.6
Volume: 1413627
4:00 PM on
December 1, 2020
Copyright West LLC. Minimum 15 minutes delayed.

Company Presentation